PureTech Health plc
PRTCY- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001782999
No open-market purchases or sales by PureTech Health plc insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Other share classesPTCHF
Q2 2025 vs. Q1 2025
How the institutions holding PureTech Health plc changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 6 | 8 | +2 |
| Shares | 392.5K | 353.5K | −39.0K (−9.9%) |
| Value | $2.32M | $2.33M | +$12.4K (+0.5%) |
New holders (3)
Institutions that held PureTech Health plc at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Diadema Partners LP | 7,324 | $126.3K | 0.08% |
| Persistent Asset Partners Ltd | 1,685 | $29.1K | 0.03% |
| Atlantic Union Bankshares Corp | 115 | $1.98K | 0.00% |
Sold out (1)
Institutions that held PureTech Health plc at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Morgan Stanley | 100 | $1.98K |